(4-(tert-Butyl)phenyl)(2-chloropyridin-4-yl)methanone, 95%, 100mg

EDTA sal dipotásica dihidrato, mínimo 99%, para síntesis, 250 g, envase de plástico.

Fmoc-(S)-3-amino-3-(3-nitrophenyl)propanoic acid, 97%, 5g

7-Bromo-1H-quinoxalin-2-one, 95.0%, 5g

1,2,3,4-Tetrahydroquinoline-6-carboxylic acid, 95.0%, 250mg

2-(P-tolyl)pyridin-3-amine, 98%, 500mg

[(oxiran-2-yl)methyl]dipropylamine, 95.0%, 2g

2-Hydroxy-4-methoxyaniline Hydrochloride>98.0%(N)5g

Methyl 2-amino-6-bromobenzoate, 95.0%, 25g

4-(Methylsulfonyl)azepane hydrochloride, 98%, 500mg

5-IODO-2-METHYL-3(2H)-PYRIDAZINONE, 95.0%, 1g

Sarcosine tert-butyl ester hydrochloride, 95%, 25g

Methyl 3-(((benzyloxy)carbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate, 98%, 500mg